|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
Our everyday lives are becoming dependent on smart phones and ‘cloud’ technologies. My sons (both in their early 20s) are constantly on their iPhones, trawling social media, gaming or taking ‘selfies’. Ironically, mobile phones are used more for managing our lives than for audible communication. On them, we can book flights and remotely change the central heating setting in our homes. This is the age we now live in, whether we like it or not. The ‘Internet of Things’ (IoT) is infiltrating every facet of our personal and working lives. Even the pharmaceutical industry – historically very conservative in its practices and slow to change – is moving with the times.
In this edition, Eva Weber at ABBYY Europe gives a vision of the factory of the future, where she predicts we will see greater integration of robotics with optical recognition systems throughout the manufacturing chain (page 22). Jeff Hackney and Mike Boudreaux at Emerson also describe how the IoT is influencing practices relating to data management within the healthcare industries – both in the production sectors and for the design of medical devices (page 61).
Data integrity is vitally important within pharma. Articles from Piritta Maunu at Vaisala (page 18) and Léon van Deurse at Chemgineering (page 40) provide insights into the current practices for ensuring IT security and information integrity for computerised systems, introducing the soon-to-become-familiar acronyms of GAMP 5, ITIL and COBIT.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
TP3 Global receives Royal recognition by winning the Queen’s Awards for Enterprise 2018
Birmingham, UK, 23 April 2018 – TP3
Global, a leading global innovator and provider of thermal protection
for temperature sensitive cargo, is pleased to announce it has
been awarded the 2018 Queen’s Awards for
Enterprise in the International Trade category for its globally-recognised
Silverskin™ brand.
More info >> |
|
 |
White Papers |
 |
|
Is Your Biobank Ready for the Challenge of Biomarker-based Research?
BioFortis
Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems. Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
More info >> |
|
 |
Industry Events |
 |
SMI Immuno-Oncology Conference
25-27 September 2018, Copthorne Tara Hotel, London, UK
Immuno-Oncology is a fast-paced field with massive potential to deliver
successful and durable cancer therapies, and SMi's Immuno-Oncology Conference will focus on a few key areas of
the field with a representation of the whole industry under each area. These
areas will be drawn together to look towards the future of Immuno-oncology and
how the field can progress.
More info >> |
|
|
